These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 1867641

  • 1. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Boise L, Westin E, Howe C, Pettit GR, Turner A, McCrady C.
    Biochem Pharmacol; 1991 Jul 25; 42(4):853-67. PubMed ID: 1867641
    [Abstract] [Full Text] [Related]

  • 2. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S.
    Biochem Pharmacol; 1994 Mar 02; 47(5):839-52. PubMed ID: 8135859
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 4. Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.
    Grant S, Jarvis WD, Turner AJ, Wallace HJ, Pettit GR.
    Br J Haematol; 1992 Nov 15; 82(3):522-8. PubMed ID: 1486032
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J, Freemerman AJ, Wu-Pong S, Jarvis WD, Grant S.
    Biochem Pharmacol; 1997 Sep 01; 54(5):563-73. PubMed ID: 9337072
    [Abstract] [Full Text] [Related]

  • 6. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S, Wang Z, Grant S.
    Mol Pharmacol; 2003 Jan 01; 63(1):232-42. PubMed ID: 12488556
    [Abstract] [Full Text] [Related]

  • 7. Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML.
    Elgie AW, Sargent JM, Alton P, Peters GJ, Noordhuis P, Williamson CJ, Taylor CG.
    Leuk Res; 1998 Apr 01; 22(4):373-8. PubMed ID: 9669842
    [Abstract] [Full Text] [Related]

  • 8. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S, Vrana JA, Bartimole TM, Freemerman AJ, Jarvis WD, Kramer LB, Krystal G, Dent P, Grant S.
    Mol Pharmacol; 1997 Dec 01; 52(6):1000-9. PubMed ID: 9396780
    [Abstract] [Full Text] [Related]

  • 9. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
    Vrana JA, Rao AS, Wang Z, Jarvis WD, Grant S.
    Int J Oncol; 1998 Apr 01; 12(4):927-34. PubMed ID: 9499457
    [Abstract] [Full Text] [Related]

  • 10. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
    Ross DD, Joneckis CC, Song TH, Wu RK.
    Cancer Res; 1988 Feb 01; 48(3):517-21. PubMed ID: 3335018
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
    Jarvis WD, Fornari FA, Tombes RM, Erukulla RK, Bittman R, Schwartz GK, Dent P, Grant S.
    Mol Pharmacol; 1998 Nov 01; 54(5):844-56. PubMed ID: 9804619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS, Freemerman AJ, Jarvis WD, Chelliah J, Bear HD, Mikkelsen R, Grant S.
    Leukemia; 1996 Jul 01; 10(7):1150-8. PubMed ID: 8683995
    [Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 01; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 16. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P, Kazemier KM, Kasperrs GJ, Peters GJ.
    Leuk Res; 1996 Feb 01; 20(2):127-34. PubMed ID: 8628011
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
    Cragg LH, Andreeff M, Feldman E, Roberts J, Murgo A, Winning M, Tombes MB, Roboz G, Kramer L, Grant S.
    Clin Cancer Res; 2002 Jul 01; 8(7):2123-33. PubMed ID: 12114412
    [Abstract] [Full Text] [Related]

  • 18. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
    Momparler RL, Onetto-Pothier N, Bouffard DY, Momparler LF.
    Cancer Chemother Pharmacol; 1990 Jul 01; 27(2):141-6. PubMed ID: 2249330
    [Abstract] [Full Text] [Related]

  • 19. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 20. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
    Gandhi V, Estey E, Du M, Keating MJ, Plunkett W.
    Clin Cancer Res; 1997 Sep 01; 3(9):1539-45. PubMed ID: 9815841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.